Microplastics and Misinformation: What Science Really Says
November 12, 2025
Brand Name :
Synonyms :
Class :
It may diminish the serum concentration when combined with colesevelam
may increase the Glucose-lowering effect of SGLT2 Inhibitors
may increase the therapeutic efficacy of each other when combined
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may increase the hypoglycaemic effect
may increase the hypoglycaemic effect
It may enhance toxicity when combined with cholic acid by diminishing the elimination
It may enhance the effect when combined with tafamidis meglumine
fibric acid derivatives increase the effect of hypoglycemia of sulfonylureas
fibric acid derivatives increase the effect of hypoglycemia of sulfonylureas
fibric acid derivatives increase the effect of hypoglycemia of sulfonylureas
fibric acid derivatives increase the effect of hypoglycemia of sulfonylureas
fibric acid derivatives increase the effect of hypoglycemia of sulfonylureas
When alprazolam and glyburide is used together, this leads to reduction in the alprazolam’s metabolism
When halometasone is used together with glyburide, this leads to elevated risk or seriousness of hyperglycemia
When glyburide is used together with diazoxide, this leads to reduction in therapeutic effectiveness of glyburide
methylprednisolone hemisuccinateÂ
When methylprednisolone hemisuccinate is aided with glyburide, this leads to elevated hyperglycemia risk
when both drugs are combined, there may be a decreased level of serum concentration of glyburide   
the effect of glyburide is increased by fluorouracil by the action on CYP2C9/10 hepatic enzyme metabolism
it increases the effect or level of ruxolitinib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
may enhance the hypoglycemic effect of Agents with blood Glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood Glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood Glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood Glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood Glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood glucose lowering effects
may enhance the hypoglycemic effect of Agents with blood glucose lowering effects
may enhance the hypoglycemic effect of antidiabetic agents
may enhance the hypoglycemic effect of antidiabetic agents
may enhance the hypoglycemic effect of antidiabetic agents
may enhance the hypoglycemic effect of antidiabetic agents
may enhance the hypoglycemic effect of antidiabetic agents
it may increase the toxicity of each other
may increase the hypoglycemic effect
may increase the hypoglycemic effect
may increase the hypoglycemic effect of beta blockers
may enhance the effect of sulfonylureas
probenecid could potentially lead to an elevation in the concentration serum of sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas